USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 205.89M | 223.27M | 250.22M | 226.20M | 213.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 205.89M | 223.27M | 250.22M | 226.20M | 213.67M |
| Cost of Revenue | 48.72M | 48.34M | 59.44M | 49.41M | 48.82M |
| Gross Profit | 157.17M | 174.93M | 190.78M | 176.79M | 164.86M |
| SG&A Expenses | 158.62M | 165.79M | 176.91M | 159.54M | 163.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 207.33M | 214.13M | 236.34M | 208.95M | 212.45M |
| Operating Income | -1.45M | 9.14M | 13.87M | 17.25M | 1.22M |
| Income Before Tax | -804.00K | -18.90M | 15.47M | 4.18M | 1.79M |
| Income Tax Expenses | 6.09M | 9.05M | 8.51M | 5.77M | 8.46M |
| Earnings from Continuing Operations | -6.89M | -27.95M | 6.96M | -1.60M | -6.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.33M | 6.57M | 556.00K | -180.00K | 140.00K |
| Net Income | -5.56M | -21.38M | 7.52M | -1.78M | -6.52M |
| EBIT | -1.45M | 9.14M | 13.87M | 17.25M | 1.22M |
| EBITDA | 6.67M | 16.82M | 22.15M | 25.81M | 9.14M |
| EPS Basic | -0.30 | -1.16 | 0.41 | -0.10 | -0.36 |
| Normalized Basic EPS | 0.05 | 0.70 | 0.56 | 0.59 | 0.07 |
| EPS Diluted | -0.30 | -1.16 | 0.41 | -0.10 | -0.36 |
| Normalized Diluted EPS | 0.05 | 0.70 | 0.56 | 0.59 | 0.07 |
| Average Basic Shares Outstanding | 18.50M | 18.49M | 18.40M | 18.30M | 18.29M |
| Average Diluted Shares Outstanding | 18.50M | 18.49M | 18.41M | 18.30M | 18.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |